Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Bionomics Limited BNOEF OTC

Other OTC • Healthcare • Biotechnology • AU • USD

SharesGrow Score
38/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Bionomics Limited (BNOEF) — Analyst outlook / Analyst consensus target is. Based on 3 analyst ratings, the consensus is bullish — 2 Buy, 1 Hold.

BNOEF Analyst Ratings

Buy
3
Ratings
2 Buy
1 Hold
Based on 3 analysts giving stock ratings to Bionomics Limited in the past 3 months
Rating breakdown
Buy
2 67%
Hold
1 33%
67%
Buy
2 analysts
33%
Hold
1 analysts
0%
Sell
0 analysts

People Also View

IGXT
IGXT
IntelGenx Technologies Corp.
$0.17
+0.00%
 CPIVF
CPIVF
Captiva Verde Wellness Corp.
$0.05
+230.00%
 BETRF
BETRF
BetterLife Pharma Inc.
$0.05
+26.83%
 PHRRF
PHRRF
PharmaTher Holdings Ltd.
$0.05
-0.96%
 LLY
LLY
Eli Lilly and Company
$905.13
-1.88%
 JNJ
JNJ
Johnson & Johnson
$238.67
-0.60%
 ABBV
ABBV
AbbVie Inc.
$208.43
-0.87%
 RHHBF
RHHBF
Roche Holding AG
$415.00
-0.84%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message